Arcellx, Inc. (ACLX)
USD 58.3
(-6.63%)
USD 58.3
(-6.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -296.95 Million USD | -1339.8% |
| 2022 | 23.95 Million USD | 122.92% |
| 2021 | -104.51 Million USD | -124.3% |
| 2020 | -46.59 Million USD | -34.76% |
| 2019 | -34.57 Million USD | -137.98% |
| 2018 | -14.53 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -25.94 Million USD | 61.52% |
| 2024 Q1 | -67.42 Million USD | 77.3% |
| 2023 Q3 | -17.4 Million USD | 91.72% |
| 2023 FY | -296.95 Million USD | -1339.8% |
| 2023 Q1 | -187.24 Million USD | -881.75% |
| 2023 Q4 | -296.95 Million USD | -1606.66% |
| 2023 Q2 | -210.03 Million USD | -12.17% |
| 2022 Q3 | 30.1 Million USD | 122.3% |
| 2022 Q2 | -135.02 Million USD | -10.73% |
| 2022 Q1 | -121.94 Million USD | -16.68% |
| 2022 FY | 23.95 Million USD | 122.92% |
| 2022 Q4 | 23.95 Million USD | -20.44% |
| 2021 Q1 | 46.59 Million USD | 200.0% |
| 2021 Q3 | -69.82 Million USD | 0.0% |
| 2021 FY | -104.51 Million USD | -124.3% |
| 2021 Q4 | -104.51 Million USD | -49.69% |
| 2020 FY | -46.59 Million USD | -34.76% |
| 2020 Q4 | -46.59 Million USD | 0.0% |
| 2019 FY | -34.57 Million USD | -137.98% |
| 2018 FY | -14.53 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -430.851% |
| Alkermes plc | -166.73 Million USD | -78.098% |
| Agenus Inc. | 274.13 Million USD | 208.325% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 115.881% |
| Aptorum Group Limited | 1.35 Million USD | 21982.678% |
| Ardelyx, Inc. | 34.51 Million USD | 960.449% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 7038.271% |
| Bicycle Therapeutics plc | -481.46 Million USD | 38.322% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 921.165% |
| ChromaDex Corporation | -24.04 Million USD | -1134.855% |
| Chimerix, Inc. | -25.51 Million USD | -1063.765% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4361.693% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1154.205% |
| CRISPR Therapeutics AG | -150.84 Million USD | -96.863% |
| Precision BioSciences, Inc. | -85.41 Million USD | -247.685% |
| Dyadic International, Inc. | -6.37 Million USD | -4555.901% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1763.792% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3974.207% |
| Lantern Pharma Inc. | -21.7 Million USD | -1268.263% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -168.65% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3375.967% |
| Incyte Corporation | -3.17 Billion USD | 90.647% |
| IO Biotech, Inc. | -140.69 Million USD | -111.059% |
| Jaguar Health, Inc. | 29.39 Million USD | 1110.371% |
| Novavax, Inc. | -298.29 Million USD | 0.448% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5664.137% |
| Opthea Limited | 28.15 Million USD | 1154.634% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1668.765% |
| ContextLogic Inc. | -232 Million USD | -27.999% |
| MiMedx Group, Inc. | -33.9 Million USD | -775.956% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3012.781% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -12716.337% |
| NextCure, Inc. | -6.47 Million USD | -4484.808% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -488.024% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4555.244% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2541.433% |
| Vaxcyte, Inc. | -368.22 Million USD | 19.355% |
| PDS Biotechnology Corporation | -32.7 Million USD | -807.881% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1818.706% |
| Pharming Group N.V. | 109.8 Million USD | 370.444% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1607.048% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -69.468% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1503.457% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1503.457% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4082.507% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4967.543% |
| Acelyrin, Inc. | -216.9 Million USD | -36.908% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5193.117% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -17124.942% |
| Summit Therapeutics Inc. | 34.67 Million USD | 956.428% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4265.104% |
| Senti Biosciences, Inc. | 1.74 Million USD | 17166.552% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -60.86% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -283.414% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4798.68% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 297745.561% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 47386.306% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -153.711% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -76.516% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 367.843% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3809.4% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -129.997% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4407.111% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -22.526% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1595.954% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 6.235% |
| MEI Pharma, Inc. | -3.7 Million USD | -7915.061% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2473.575% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 283.6% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1168.463% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3974.207% |
| Precigen, Inc. | -481 Thousand USD | -61637.63% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2208.927% |
| AlloVir, Inc. | -62.69 Million USD | -373.678% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -433.963% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 581.559% |
| ImmuCell Corporation | 10.99 Million USD | 2801.936% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -92.647% |
| Onconetix, Inc. | 5.33 Million USD | 5669.943% |
| PureTech Health plc | -167.19 Million USD | -77.61% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -874.911% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1453.29% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5949.256% |
| Seer, Inc. | -4.24 Million USD | -6903.726% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1135.42% |
| Innoviva, Inc. | 255.56 Million USD | 216.198% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -431.573% |
| ESSA Pharma Inc. | -33.62 Million USD | -783.236% |
| GlycoMimetics, Inc. | -40.98 Million USD | -624.563% |
| GT Biopharma, Inc. | -1.02 Million USD | -28985.015% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -338.101% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 584.774% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -121.48% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2043.173% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -928.533% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -394088.547% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -862.212% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3523.712% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -9390.454% |
| Soligenix, Inc. | -4.95 Million USD | -5897.217% |
| Century Therapeutics, Inc. | 847 Thousand USD | 35159.976% |
| Kura Oncology, Inc. | -20.11 Million USD | -1376.081% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -625.597% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3436.056% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 16401.192% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9188.646% |
| Autolus Therapeutics plc | -186.59 Million USD | -59.142% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -502.3% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -7.674% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 966.575% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 280.667% |
| GRI Bio, Inc. | -1.79 Million USD | -16452.843% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3205.761% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -792.919% |
| IGM Biosciences, Inc. | -72.6 Million USD | -308.999% |
| INmune Bio, Inc. | -25.41 Million USD | -1068.62% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 296.725% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -486.19% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1727.504% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10193.436% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 881.16% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -621.034% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1031.341% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 178.571% |
| Verastem, Inc. | -37.27 Million USD | -696.604% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3172.986% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -472.593% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1862.061% |
| Histogen Inc. | -7.48 Million USD | -3866.315% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1274.372% |
| Surrozen, Inc. | -32.66 Million USD | -809.129% |
| Organovo Holdings, Inc. | -1.5 Million USD | -19605.242% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6964.562% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1666.217% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 11451.606% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7245.284% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3443.165% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -583.574% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1937.188% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 6.26% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -41026.499% |
| Apollomics, Inc. | -27.39 Million USD | -983.986% |
| Amarin Corporation plc | -191.04 Million USD | -55.443% |
| Mesoblast Limited | 55.96 Million USD | 630.633% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1936.19% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1074.118% |
| Synaptogenix, Inc. | -28.66 Million USD | -936.087% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -31626.282% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 709.37% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -34346.327% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3986.908% |
| Exelixis, Inc. | -73.05 Million USD | -306.513% |
| Better Therapeutics, Inc. | -860 Thousand USD | -34430.0% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1136.655% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -23.03% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40443.937% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3892.372% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 23780.861% |
| Gritstone bio, Inc. | 39.49 Million USD | 851.983% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -253.097% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11181.999% |
| Avid Bioservices, Inc. | 169.72 Million USD | 274.961% |
| Insmed Incorporated | 721.62 Million USD | 141.152% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3148.456% |
| MediWound Ltd. | -5.32 Million USD | -5479.82% |
| OmniAb, Inc. | 9.2 Million USD | 3326.752% |
| Alector, Inc. | -35.63 Million USD | -733.286% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 445.416% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5925.933% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2343.055% |
| Zai Lab Limited | -775 Million USD | 61.683% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 187.198% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1279.596% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -260.036% |
| Immunic, Inc. | -45.34 Million USD | -554.958% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -53.693% |
| Veracyte, Inc. | -203.82 Million USD | -45.693% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 146.524% |
| FibroGen, Inc. | 56.76 Million USD | 623.117% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3434.733% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -10404.046% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -14243.386% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.469% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -8788.297% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -78.929% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1762.513% |
| Galecto, Inc. | -21.21 Million USD | -1299.689% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1148.51% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 118.922% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1113.46% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2480.673% |
| XBiotech Inc. | -200.02 Million USD | -48.462% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -253.097% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6658.26% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -742.123% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -284.571% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5318.028% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -74.256% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -221.474% |
| Vaxxinity, Inc. | 10.13 Million USD | 3030.892% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 140.333% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2657.897% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -350.237% |
| NexImmune, Inc. | -3.13 Million USD | -9376.446% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -8500.814% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1865.119% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -995.786% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3208.336% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -238276.881% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -631.928% |
| Ainos, Inc. | 4.07 Million USD | 7382.081% |
| Pluri Inc. | 22.82 Million USD | 1400.793% |
| Prothena Corporation plc | -608.34 Million USD | 51.186% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -150.057% |
| Celularity Inc. | 65.19 Million USD | 555.527% |
| Rallybio Corporation | -24.1 Million USD | -1132.089% |
| Cue Biopharma, Inc. | -33.81 Million USD | -778.08% |
| MeiraGTx Holdings plc | -40.3 Million USD | -636.832% |
| Omeros Corporation | 331.17 Million USD | 189.668% |
| Humacyte, Inc. | -22.48 Million USD | -1220.635% |
| Immunocore Holdings plc | -358.59 Million USD | 17.188% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1108.374% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -860.998% |
| Blueprint Medicines Corporation | 702.83 Million USD | 142.251% |
| CalciMedica, Inc. | -5.53 Million USD | -5269.946% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -57.772% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2807.362% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -641.709% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -793.026% |
| Pulmatrix, Inc. | -10.41 Million USD | -2750.706% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4868.345% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -678.559% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -166.564% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -395.392% |
| Cytokinetics, Incorporated | 642.37 Million USD | 146.228% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4999.742% |
| Nutriband Inc. | -251.65 Thousand USD | -117901.089% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -770.36% |
| Vor Biopharma Inc. | 4.3 Million USD | 7006.0% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.08% |
| Evogene Ltd. | -19.63 Million USD | -1412.468% |
| ProKidney Corp. | -56.23 Million USD | -428.057% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -510.121% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3114.81% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 121.773% |
| CorMedix Inc. | -43.05 Million USD | -589.758% |
| BioLineRx Ltd. | 7.33 Million USD | 4147.955% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -981.223% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 743.504% |
| Atai Life Sciences N.V. | -28.55 Million USD | -939.842% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 13413.344% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1201.534% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1774.418% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -295.554% |
| MediciNova, Inc. | -50.78 Million USD | -484.753% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -276.826% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1320006.69% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4502.153% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -48.612% |
| Biomea Fusion, Inc. | -166.57 Million USD | -78.278% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -65.921% |
| Mereo BioPharma Group plc | -51.46 Million USD | -476.965% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -213.102% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -1.089% |
| Absci Corporation | -72.59 Million USD | -309.044% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6603.679% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -26.669% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -215.205% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -210.314% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -660.008% |
| Allakos Inc. | -24.97 Million USD | -1089.021% |
| Imunon, Inc. | -4.21 Million USD | -6947.186% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1914.367% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -119.319% |
| BioAtla, Inc. | -109.01 Million USD | -172.411% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40443.937% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -31524.92% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2581.681% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1300.547% |
| XOMA Corporation | -29 Million USD | -923.993% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1693.225% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3193.678% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3886.549% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -138.26% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -42.656% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -263.123% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -220.125% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -34462.794% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7623.225% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18398.098% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 121.505% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24893.624% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6862.879% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 361.681% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 412759.459% |
| Orgenesis Inc. | 21.78 Million USD | 1463.193% |
| Entera Bio Ltd. | -10.62 Million USD | -2693.847% |
| GH Research PLC | -78.07 Million USD | -280.34% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1232.367% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1013.913% |
| Xencor, Inc. | 29.64 Million USD | 1101.747% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -14975.449% |
| Replimune Group, Inc. | 1.41 Million USD | 21131.02% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -121152.879% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -134.904% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24893.624% |
| Portage Biotech Inc. | -4.98 Million USD | -5861.815% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1320006.69% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -349.106% |
| OncoCyte Corporation | -6.56 Million USD | -4424.73% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 33190.45% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6418.465% |
| Purple Biotech Ltd. | -14.13 Million USD | -2000.424% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1150.034% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4437.173% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1679.026% |
| HilleVax, Inc. | -165.48 Million USD | -79.447% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -11600.473% |
| Tharimmune, Inc. | -10.93 Million USD | -2615.578% |
| Genprex, Inc. | -6.73 Million USD | -4307.456% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 19.481% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -235.697% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -21096.146% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -8852.754% |
| OKYO Pharma Limited | -826.84 Thousand USD | -35814.461% |
| Savara Inc. | 153 Thousand USD | 194190.196% |
| Curis, Inc. | -23.88 Million USD | -1143.178% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5657.331% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -38167.192% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4683.473% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 25159.747% |
| BeiGene, Ltd. | -2.25 Billion USD | 86.82% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2506.759% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 51.175% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -60.011% |
| Erasca, Inc. | -37.21 Million USD | -697.931% |
| bluebird bio, Inc. | 108.57 Million USD | 373.515% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22957.661% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 178.405% |
| DBV Technologies S.A. | -126.98 Million USD | -133.851% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22957.661% |
| Moderna, Inc. | -2.9 Billion USD | 89.785% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2768.605% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2632.407% |
| Molecular Templates, Inc. | 707 Thousand USD | 42102.546% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -846.6% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 185.675% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -261.87% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -223.731% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -820.172% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -763.853% |
| MacroGenics, Inc. | -66.98 Million USD | -343.32% |
| RenovoRx, Inc. | -1.17 Million USD | -25216.113% |
| Adicet Bio, Inc. | -138.78 Million USD | -113.967% |
| Prime Medicine, Inc. | -27.94 Million USD | -962.804% |
| Aditxt, Inc. | 18.12 Million USD | 1738.761% |
| Adagene Inc. | -87.62 Million USD | -238.887% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7029.111% |
| Quantum-Si incorporated | -118.55 Million USD | -150.477% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 924.769% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3873.114% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -512.171% |
| SciSparc Ltd. | -2.06 Million USD | -14280.533% |
| Vericel Corporation | 1.27 Million USD | 23354.346% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2376.363% |
| Minerva Neurosciences, Inc. | 41 Million USD | 824.213% |
| Generation Bio Co. | 31.44 Million USD | 1044.283% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -69.338% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -860.314% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 354.696% |
| Invivyd, Inc. | -198.47 Million USD | -49.619% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -228.966% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -12285.18% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -319.491% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4251.033% |
| 2seventy bio, Inc. | 181.71 Million USD | 263.42% |
| ADMA Biologics, Inc. | 90.06 Million USD | 429.712% |
| Clene Inc. | 3.34 Million USD | 8990.958% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3169.489% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1280.494% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4502.153% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 13.706% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1042.16% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 267.144% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7157.806% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 6036.785% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5600.864% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -127.896% |
| Evaxion Biotech A/S | 5.28 Million USD | 5716.924% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -163.803% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -126.214% |
| Trevena, Inc. | 2.25 Million USD | 13251.373% |
| Surrozen, Inc. | -32.66 Million USD | -809.129% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -476.506% |
| Cingulate Inc. | 3.08 Million USD | 9733.102% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -10010.93% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4231.877% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3096.112% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -274.366% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -125.906% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -181.365% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7431.964% |
| Kronos Bio, Inc. | -36.05 Million USD | -723.648% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3256.106% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20465.716% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -447.327% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2159.862% |
| ImmunityBio, Inc. | 618.22 Million USD | 148.034% |
| Korro Bio, Inc. | -132.94 Million USD | -123.372% |
| Kineta, Inc. | -4.54 Million USD | -6439.485% |
| BioVie Inc. | -17.73 Million USD | -1574.668% |
| Codexis, Inc. | -43.27 Million USD | -586.275% |
| Celularity Inc. | 65.19 Million USD | 555.527% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9270.716% |
| Celcuity Inc. | 6.78 Million USD | 4477.646% |
| Virax Biolabs Group Limited | -3.36 Million USD | -8725.05% |
| Cibus, Inc. | -8.07 Million USD | -3576.133% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6921.944% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 6597.987% |
| IN8bio, Inc. | -16.38 Million USD | -1711.935% |
| Kodiak Sciences Inc. | -103.87 Million USD | -185.88% |
| Annexon, Inc. | -193.75 Million USD | -53.265% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 824983.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1597.0% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8353.117% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 128.167% |
| Eyenovia, Inc. | 1.25 Million USD | 23692.399% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1203.728% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9056.892% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -793.187% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1422.393% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -404.387% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1332.711% |
| Moolec Science SA | 117.61 Thousand USD | 252580.955% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -673.348% |
| Geron Corporation | 14.76 Million USD | 2111.774% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -683.158% |
| Royalty Pharma plc | 5.65 Billion USD | 105.248% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -109.982% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4148.676% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5437.308% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -111.011% |
| Humacyte, Inc. | -22.48 Million USD | -1220.635% |
| Structure Therapeutics Inc. | -124.33 Million USD | -138.829% |
| 89bio, Inc. | -289.05 Million USD | -2.735% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1076.444% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -16554.964% |
| Genelux Corporation | -6.89 Million USD | -4204.363% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -856.109% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 455.217% |
| Notable Labs, Ltd. | -9.77 Million USD | -2937.623% |
| Liquidia Corporation | -80.17 Million USD | -270.383% |
| Mustang Bio, Inc. | -3.73 Million USD | -7848.555% |
| Immunovant, Inc. | -635.22 Million USD | 53.252% |
| Quantum-Si incorporated | -118.55 Million USD | -150.477% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1590.72% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -7067.705% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3799.489% |
| Acasti Pharma Inc. | -23 Million USD | -1190.841% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -8719.062% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1727.504% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -115.593% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -9428.996% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1235.723% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1499.214% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -75.426% |
| PepGen Inc. | -60.67 Million USD | -389.464% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1192.47% |
| United Therapeutics Corporation | -507.7 Million USD | 41.509% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1452.64% |
| Solid Biosciences Inc. | -47.75 Million USD | -521.902% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -34346.327% |
| Immuneering Corporation | -54.94 Million USD | -440.485% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6964.562% |
| Silo Pharma, Inc. | -3.52 Million USD | -8325.995% |
| Belite Bio, Inc | -87.27 Million USD | -240.271% |
| XOMA Corporation | -29 Million USD | -923.993% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -320.043% |
| Bionomics Limited | 227 Million USD | 230.813% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -155.377% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11623.569% |
| uniQure N.V. | -102.95 Million USD | -188.446% |
| Cassava Sciences, Inc. | -121.13 Million USD | -145.144% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7029.111% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 825.154% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2382.719% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -9497.246% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 280249.057% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9056.892% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3434.733% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3904.288% |
| Altimmune, Inc. | -134.48 Million USD | -120.808% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 249.93% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11623.569% |
| Compugen Ltd. | -12.9 Million USD | -2201.286% |
| Peak Bio, Inc. | 10.34 Million USD | 2971.89% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -104832.155% |
| Benitec Biopharma Inc. | -50.58 Million USD | -487.082% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -184.612% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1611.621% |
| Zura Bio Limited | -99.8 Million USD | -197.535% |
| PolyPid Ltd. | 6.17 Million USD | 4912.934% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 500.645% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1611.621% |
| Instil Bio, Inc. | 75.35 Million USD | 494.063% |
| argenx SE | -2.02 Billion USD | 85.363% |
| Immunome, Inc. | -97.02 Million USD | -206.051% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1220.107% |
| Verona Pharma plc | -220.44 Million USD | -34.71% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -313.919% |
| Shattuck Labs, Inc. | -121.42 Million USD | -144.563% |
| CervoMed Inc. | -7.79 Million USD | -3710.649% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -60.086% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6690.716% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -125.412% |
| Moolec Science SA | 117.61 Thousand USD | 252580.955% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -12879.064% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1967.851% |
| AnaptysBio, Inc. | -18.15 Million USD | -1536.042% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1536.132% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -321.929% |
| NeurAxis, Inc. | 145.7 Thousand USD | 203914.688% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2743.857% |
| Lumos Pharma, Inc. | -28.49 Million USD | -942.214% |
| Achilles Therapeutics plc | -126.92 Million USD | -133.965% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -313.919% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -45186.627% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1329.482% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20465.716% |
| Nutriband Inc. | -251.65 Thousand USD | -117901.089% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2154.635% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3891.371% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 187.29% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1351.14% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 33.636% |
| Palisade Bio, Inc. | -12.06 Million USD | -2361.726% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -111.643% |
| Beam Therapeutics Inc. | -262.72 Million USD | -13.031% |
| Neurogene Inc. | -131.95 Million USD | -125.045% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1461.194% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5985.205% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 21.271% |
| Sesen Bio, Inc. | -112.55 Million USD | -163.838% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -197.374% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -12548.389% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -660.923% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -256.569% |
| Athira Pharma, Inc. | -88.99 Million USD | -233.664% |
| Vaccinex, Inc. | -1.28 Million USD | -22955.745% |
| HCW Biologics Inc. | 2.85 Million USD | 10495.229% |
| XOMA Corporation | -29 Million USD | -923.993% |
| Nektar Therapeutics | 210.24 Million USD | 241.247% |
| Arvinas, Inc. | -313.8 Million USD | 5.367% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18398.098% |
| Merus N.V. | -192.88 Million USD | -53.957% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 595.054% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4180.167% |
| Rezolute, Inc. | -68.16 Million USD | -335.627% |
| Clene Inc. | 3.34 Million USD | 8990.958% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2151.9% |
| BeyondSpring Inc. | -13.75 Million USD | -2058.909% |
| Synlogic, Inc. | -6.68 Million USD | -4342.154% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 26286.772% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3412.218% |
| Peak Bio, Inc. | 10.34 Million USD | 2971.89% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -260.298% |
| Krystal Biotech, Inc. | -350.23 Million USD | 15.212% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 339.241% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -75.719% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9305.906% |
| MannKind Corporation | 143.89 Million USD | 306.366% |
| Ikena Oncology, Inc. | -109.15 Million USD | -172.049% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3822.309% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -797.154% |
| Gossamer Bio, Inc. | 180.35 Million USD | 264.652% |
| CohBar, Inc. | -5.93 Million USD | -4907.106% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -898.245% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6603.679% |
| Legend Biotech Corporation | -949.39 Million USD | 68.721% |
| Mural Oncology plc | -255.84 Million USD | -16.07% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1021.8% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6203.981% |
| Disc Medicine, Inc. | -358.28 Million USD | 17.116% |
| Champions Oncology, Inc. | 4.81 Million USD | 6271.197% |
| REGENXBIO Inc. | 54.76 Million USD | 642.211% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -110331.487% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -96.63% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3195.138% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -268.055% |
| Vaxart, Inc. | -8.24 Million USD | -3503.422% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -491.786% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -133.521% |
| Cellectis S.A. | -43.85 Million USD | -577.136% |
| Longeveron Inc. | -2.9 Million USD | -10111.761% |
| Repare Therapeutics Inc. | -107.85 Million USD | -175.323% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 130.666% |
| Inozyme Pharma, Inc. | 12 Million USD | 2573.825% |
| Revolution Medicines, Inc. | -608.2 Million USD | 51.175% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -24042.927% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -12.01% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -97.877% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1797.859% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -40029.459% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.895% |
| Denali Therapeutics Inc. | -74.86 Million USD | -296.658% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2376.363% |
| Veru Inc. | 4.77 Million USD | 6312.551% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2540.566% |
| Cingulate Inc. | 3.08 Million USD | 9733.102% |
| Passage Bio, Inc. | 4.58 Million USD | 6576.728% |
| Context Therapeutics Inc. | -14.44 Million USD | -1955.097% |
| Exicure, Inc. | 5.84 Million USD | 5177.073% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -28.901% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -650.462% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1992.537% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -404.85% |
| Nuvalent, Inc. | -335.38 Million USD | 11.458% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 17222.238% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -298.698% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3240.36% |
| OmniAb, Inc. | 9.2 Million USD | 3326.752% |
| Anew Medical, Inc. | 1.43 Million USD | 20830.559% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1912.736% |
| Lipocine Inc. | -4.75 Million USD | -6145.709% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -170.385% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2049.695% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -486.19% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1292.986% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4318.36% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -351.119% |
| Ocugen, Inc. | -32.52 Million USD | -813.127% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -247.015% |
| Q32 Bio Inc. | -37.94 Million USD | -682.539% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -47186.306% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2094.974% |
| Equillium, Inc. | -22.39 Million USD | -1226.179% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1061.444% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -810.167% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -119682.183% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 321.541% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 9385.741% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 90514.412% |
| Dominari Holdings Inc. | 195 Thousand USD | 152386.154% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5538.183% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3230.246% |
| Bio-Techne Corporation | 267.74 Million USD | 210.91% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1732.056% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -151.459% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3433.952% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2247.309% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -21.149% |
| Nkarta, Inc. | 57.29 Million USD | 618.26% |
| BioCardia, Inc. | 212 Thousand USD | 140174.528% |
| Iterum Therapeutics plc | 13.43 Million USD | 2309.838% |